Response of the human myocardium to ischemic injury and preconditioning: The role of cardiac and comorbid conditions, medical treatment, and basal redox status-Reference-Cited by-同舟云学术

Response of the human myocardium to ischemic injury and preconditioning: The role of cardiac and comorbid conditions, medical treatment, and basal redox status

Published:2017-04-05 Issue:4 Volume:12 Page:e0174588
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Casós Kelly,Ferrer-Curriu Gemma,Soler-Ferrer Paula,Pérez María L,Permanyer Eduard,Blasco-Lucas Arnau,Gracia-Baena Juan Manuel,Castro Miguel A,Sureda Carlos,Barquinero Jordi,Galiñanes Manuel^ORCID

Funder

Instituto de Salud Carlos III

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. The role of oxidants and free radicals in reperfusion injury;JL Zweier;Cardiovasc Res,2006

2. Cell biology of ischemia/reperfusion injury;T Kalogeris;Int Rev Cell Mol Biol,2012

3. Relationships of adiponectin with markers of systemic inflammation and insulin resistance in infants undergoing open cardiac surgery;Y Cao;Mediators Inflamm,2013

4. Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement;P Genereux;J Am Coll Cardiol,2014

5. Outcomes of coronary artery bypass graft surgery;AL Hawkes;Vasc Health Risk Manag,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical usage of ischemic tolerance-where are its limits?;Asian Journal of Surgery;2024-05

2. Investigative algorithms for disorders affecting plasma lactate dehydrogenase: a narrative review;Journal of Laboratory and Precision Medicine;2024-04

3. Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and Mechanisms;Cardiovascular Drugs and Therapy;2022-02-12

4. INFLUENCE OF INTERVAL NORMOBARIC HYPOXYTHERAPY ON THE PROCESSES OF ISCHEMIC PRECONDITIONING IN THE MYOCARDIUM OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE;Wiadomości Lekarskie;2022-01

5. Resveratrol activates PI3K/AKT to reduce myocardial cell apoptosis and mitochondrial oxidative damage caused by myocardial ischemia/reperfusion injury;Acta Histochemica;2021-07